☰

Natura Myeku, Ph.D. - Publications

Affiliations: 
2011 Biology City University of New York, New York, NY, United States 
Area:
Molecular Biology, Cell Biology, Neuroscience Biology
Tree Info Similar researchers PubMed Report error

11/15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Schaler AW, Runyan AM, Clelland CL, Sydney EJ, Fowler SL, Figueroa HY, Shioda S, Santa-Maria I, Duff KE, Myeku N. PAC1 receptor-mediated clearance of tau in postsynaptic compartments attenuates tau pathology in mouse brain. Science Translational Medicine. 13. PMID 34039738 DOI: 10.1126/scitranslmed.aba7394  0.596
2017 Myeku N, Duff KE. Targeting the 26S Proteasome To Protect Against Proteotoxic Diseases. Trends in Molecular Medicine. PMID 29233753 DOI: 10.1016/j.molmed.2017.11.006  0.568
2017 Schaler AW, Myeku N. Cilostazol, a phosphodiesterase 3 inhibitor, activates proteasome proteolysis and attenuates tauopathy and cognitive decline. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 29232559 DOI: 10.1016/j.trsl.2017.11.004  0.498
2015 Myeku N, Clelland CL, Emrani S, Kukushkin NV, Yu WH, Goldberg AL, Duff KE. Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling. Nature Medicine. PMID 26692334 DOI: 10.1038/nm.4011  0.696
2012 Myeku N, Wang H, Figueiredo-Pereira ME. cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. Neuroscience Letters. 527: 126-31. PMID 22982149 DOI: 10.1016/j.neulet.2012.08.051  0.617
2012 Congdon EE, Wu JW, Myeku N, Figueroa YH, Herman M, Marinec PS, Gestwicki JE, Dickey CA, Yu WH, Duff KE. Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy. 8: 609-22. PMID 22361619 DOI: 10.4161/Auto.19048  0.715
2012 Myeku N, Yu WH, Duff K. O4-11-03: Interaction between the ubiquitin proteasome system, autophagy and progressive tauopathy in vivo Alzheimer's & Dementia. 8: P636-P637. DOI: 10.1016/J.Jalz.2012.05.1697  0.57
2011 Myeku N, Metcalfe MJ, Huang Q, Figueiredo-Pereira M. Assessment of proteasome impairment and accumulation/aggregation of ubiquitinated proteins in neuronal cultures. Methods in Molecular Biology (Clifton, N.J.). 793: 273-96. PMID 21913107 DOI: 10.1007/978-1-61779-328-8_18  0.718
2011 Myeku N, Figueiredo-Pereira ME. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62. The Journal of Biological Chemistry. 286: 22426-40. PMID 21536669 DOI: 10.1074/Jbc.M110.149252  0.693
2010 Boamah EK, Brekman A, Tomasz M, Myeku N, Figueiredo-Pereira M, Hunter S, Meyer J, Bhosle RC, Bargonetti J. DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1. Chemical Research in Toxicology. 23: 1151-62. PMID 20536192 DOI: 10.1021/Tx900420K  0.658
2009 Arnaud LT, Myeku N, Figueiredo-Pereira ME. Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells. Journal of Neurochemistry. 110: 328-42. PMID 19457109 DOI: 10.1111/J.1471-4159.2009.06142.X  0.595
Low-probability matches (unlikely to be authored by this person)
2024 Jiang S, Sydney EJ, Runyan AM, Serpe R, Srikanth M, Figueroa HY, Yang M, Myeku N. 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy. Frontiers in Cellular Neuroscience. 18: 1338502. PMID 38638303 DOI: 10.3389/fncel.2024.1338502  0.244
2023 Jiang S, Sydney EJ, Runyan AM, Serpe R, Figueroa HY, Yang M, Myeku N. 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy. Biorxiv : the Preprint Server For Biology. PMID 36778352 DOI: 10.1101/2023.02.03.526871  0.219
2006 Myeku N. P3-154: STOPPING TRANS-SYNAPTIC PROPAGATION OF TAU BY RECEPTOR-MEDIATED CLEARANCE OF POST-SYNAPTIC TAU Alzheimer's & Dementia. 14: P1127-P1127. DOI: 10.1016/j.jalz.2018.06.1512  0.21
2023 Kesner JS, Chen Z, Shi P, Aparicio AO, Murphy MR, Guo Y, Trehan A, Lipponen JE, Recinos Y, Myeku N, Wu X. Noncoding translation mitigation. Nature. PMID 37046090 DOI: 10.1038/s41586-023-05946-4  0.142
Hide low-probability matches.